Amarin Corp Plcuk's ability to collect accounts receivable sequentially worsen to 1.49, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Amarin Plcuk's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 245 days, from 228 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 391 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2450, from overall ranking in the first quarter 2026 at 3214.

What is Receivable Turnover Ratio?
What is Amarin Corp Plcuk Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AMRN Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-30.71 %	3.68 %	8.95 %	8.48 %	-10.97 %
Y / Y Revenue Change	-41.63 %	7.41 %	-21.01 %	17.43 %	7.78 %
Receivable Turnover Ratio (TTM)	1.49	1.6	1.59	1.72	1.7
AMRN's Total Ranking	# 2450	# 3214	# 2305	# 2343	# 1993
Accounts Receivable average collection period days	246	229	230	212	215
Seq. Receivable Change	-24.48 %	-15.14 %	2.61 %	5.36 %	13 %
Seq. Revenue Change	-5.92 %	-8.3 %	-0.91 %	-31.72 %	73.12 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 120
Healthcare Sector	# 392
Overall Market	# 2450

Receivable Turnover Ratio Statistics
High	Average	Low
1.08	0.54	0.1
(Dec 31 2017)		(Dec 31 2013)

AMRN Company Profile • Back to AMRN Efficiency Comparisons • Compare AMRN Receivables Turnover Ratio to its Competitors

Financial Statements
Amarin Plcuk's Accounts Receivable	$ 93 Millions	Visit AMRN's Balance sheet
Amarin Plcuk's Sales TTM	$ 186 Millions	Visit AMRN's Income Statement
Sources of AMRN's Revenues		Visit AMRN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AMRN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AMRN's Growth Rates	AMRN's Roa	AMRN's Inventory Turnover Ratio	AMRN's Dividend Comparisons
AMRN's Profitability Ratios	AMRN's Roi	AMRN's Asset Turnover Ratio	AMRN's Dividend Growth
AMRN's Valuation Ratios	AMRN's Roe	AMRN's Financial Strength Ratios	AMRN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Intelligent Bio Solutions Inc	5.51	$ 4.215 Millions	$ 0.765 Millions
Johnson and Johnson	5.47	$ 97,929.000 Millions	$ 17,889.000 Millions
Merck and Co Inc	5.47	$ 66,569.000 Millions	$ 12,167.250 Millions
Quanterix Corporation	5.45	$ 152.716 Millions	$ 28.030 Millions
Brightspring Health Services Inc	5.45	$ 5,877.918 Millions	$ 1,079.324 Millions
Charles River Laboratories International inc	5.44	$ 3,998.987 Millions	$ 734.654 Millions
Rigel Pharmaceuticals Inc	5.43	$ 276.785 Millions	$ 50.994 Millions
Blue Water Vaccines Inc	5.42	$ 0.646 Millions	$ 0.119 Millions
Sintx Technologies Inc	5.37	$ 1.330 Millions	$ 0.248 Millions
Igc Pharma Inc	5.36	$ 1.101 Millions	$ 0.206 Millions
Strata Critical Medical Inc	5.27	$ 211.642 Millions	$ 40.126 Millions
Karyopharm Therapeutics Inc	5.27	$ 146.621 Millions	$ 27.821 Millions
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
Opus Genetics Inc	5.13	$ 9.856 Millions	$ 1.921 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Progyny Inc	5.09	$ 1,311.298 Millions	$ 257.570 Millions
Pfizer Inc	4.98	$ 63,696.000 Millions	$ 12,802.250 Millions
Stereotaxis Inc	4.98	$ 29.892 Millions	$ 6.008 Millions
Invivyd Inc	4.96	$ 58.365 Millions	$ 11.776 Millions
Agilent Technologies inc	4.96	$ 7,372.000 Millions	$ 1,487.500 Millions
Plus Therapeutics Inc	4.90	$ 4.203 Millions	$ 0.858 Millions
Abeona Therapeutics Inc	4.83	$ 30.093 Millions	$ 6.232 Millions
Xtant Medical Holdings Inc	4.81	$ 108.748 Millions	$ 22.594 Millions
Ligand Pharmaceuticals Incorporated	4.77	$ 290.542 Millions	$ 60.966 Millions
Personalis Inc	4.75	$ 69.669 Millions	$ 14.676 Millions
Privia Health Group Inc	4.75	$ 2,358.069 Millions	$ 496.945 Millions
Viatris Inc	4.68	$ 14,737.300 Millions	$ 3,151.350 Millions
Bausch and Lomb Corp	4.65	$ 5,324.000 Millions	$ 1,144.000 Millions
Davita Inc	4.64	$ 14,009.646 Millions	$ 3,018.719 Millions

Date modified: 2026-08-30T16:41:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.